Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06107361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 10, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion pushed from Mar 2026 to Jun 30, 2026
    • Study completion pushed from May 2026 to Jul 31, 2026
    • Site contact updated
    v6
  2. Site contact updatedv5
  3. Primary completion date: Dec 2025 to Mar 2026
    • Study completion date: Jan 2026 to May 2026
    v4
  4. Primary completion date: Dec 2024 to Dec 2025
    • Study completion date: Jan 2025 to Jan 2026
    • Site contact updated
    v3
  5. Start date changed from estimate of Dec 2023 to Nov 7, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Trial Details
NCT Number NCT06107361
Lead Sponsor Corewell Health East
Conditions
(from sponsor)		 Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
Related terms Phlebitis
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov